Do not take Lenalidomide (Lenalid) capsules if: Patient is pregnant.
Patient is at risk of becoming pregnant.
Patient becomes pregnant during Lenalidomide (Lenalid) capsules treatment.
Patient is breastfeeding.
Lenalidomide (Lenalid) capsules can cause an increased risk of death in people who have chronic lymphocytic leukemia (CLL). Do not take Lenalidomide (Lenalid) capsules if patient has CLL.
Patient is allergic to lenalidomide, pomalidomide or thalidomide or any of the other ingredients in Lenalidomide (Lenalid) capsules. Lenalidomide (Lenalid) capsules contains lactose.
Lenalid 5/Lenalid 10: Myelodysplastic Syndromes: Lenalidomide (Lenalid) capsules treatment should not be started in patients whose platelet levels are less than 50 x 109/L.
Other Services
Country
Account